Louisiana State Employees Retirement System Buys Shares of 6,200 The Clorox Company $CLX

Louisiana State Employees Retirement System purchased a new stake in shares of The Clorox Company (NYSE:CLX) during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 6,200 shares of the company’s stock, valued at approximately $643,000.

A number of other hedge funds and other institutional investors have also modified their holdings of CLX. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its position in shares of Clorox by 4.0% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 13,380 shares of the company’s stock valued at $1,970,000 after purchasing an additional 514 shares during the period. Woodline Partners LP lifted its holdings in shares of Clorox by 253.7% in the first quarter. Woodline Partners LP now owns 10,407 shares of the company’s stock valued at $1,532,000 after buying an additional 7,465 shares during the period. Baird Financial Group Inc. boosted its stake in Clorox by 1.7% during the second quarter. Baird Financial Group Inc. now owns 25,032 shares of the company’s stock valued at $3,006,000 after buying an additional 424 shares in the last quarter. Jump Financial LLC boosted its stake in Clorox by 173.5% during the second quarter. Jump Financial LLC now owns 12,491 shares of the company’s stock valued at $1,500,000 after buying an additional 7,924 shares in the last quarter. Finally, Bank of Nova Scotia grew its holdings in Clorox by 26.2% during the second quarter. Bank of Nova Scotia now owns 16,141 shares of the company’s stock worth $1,938,000 after acquiring an additional 3,352 shares during the period. 78.53% of the stock is currently owned by institutional investors.

Insiders Place Their Bets

In other news, Director Pierre R. Breber bought 5,000 shares of the business’s stock in a transaction on Tuesday, May 5th. The shares were bought at an average cost of $85.82 per share, with a total value of $429,100.00. Following the purchase, the director directly owned 18,000 shares in the company, valued at $1,544,760. This trade represents a 38.46% increase in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Insiders own 0.63% of the company’s stock.

Clorox Price Performance

CLX stock opened at $97.45 on Wednesday. The Clorox Company has a one year low of $84.70 and a one year high of $132.03. The firm has a 50-day moving average of $94.19 and a two-hundred day moving average of $104.20. The firm has a market capitalization of $11.78 billion, a PE ratio of 15.82, a P/E/G ratio of 0.46 and a beta of 0.54. The company has a current ratio of 0.84, a quick ratio of 0.65 and a debt-to-equity ratio of 27.03.

Clorox (NYSE:CLX) last released its earnings results on Thursday, April 30th. The company reported $1.64 earnings per share for the quarter, topping the consensus estimate of $1.55 by $0.09. The business had revenue of $1.67 billion for the quarter, compared to the consensus estimate of $1.67 billion. Clorox had a net margin of 11.18% and a return on equity of 443.64%. The firm’s quarterly revenue was up .1% compared to the same quarter last year. During the same period last year, the firm posted $1.45 earnings per share. Clorox has set its FY 2026 guidance at 5.450-5.650 EPS. On average, analysts forecast that The Clorox Company will post 5.61 earnings per share for the current year.

Analyst Upgrades and Downgrades

A number of equities research analysts have weighed in on the stock. JPMorgan Chase & Co. cut their price target on shares of Clorox from $99.00 to $95.00 and set an “underweight” rating for the company in a report on Friday, May 1st. Evercore reaffirmed an “underperform” rating and issued a $110.00 price objective on shares of Clorox in a research note on Friday, May 1st. Royal Bank Of Canada dropped their target price on shares of Clorox from $132.00 to $127.00 and set a “sector perform” rating on the stock in a report on Thursday, April 9th. Zacks Research cut shares of Clorox from a “hold” rating to a “strong sell” rating in a report on Tuesday, May 12th. Finally, The Goldman Sachs Group restated a “sell” rating and issued a $83.00 price target on shares of Clorox in a research report on Friday, May 1st. One research analyst has rated the stock with a Buy rating, eleven have given a Hold rating and five have issued a Sell rating to the company. Based on data from MarketBeat, the stock presently has an average rating of “Reduce” and an average price target of $103.40.

About Clorox

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.